Hepatitis B: Infection, vaccination and autoimmunity

Israel Medical Association Journal

Volumn 10, Issue 1, 2008, Pages 61-64

  Ram, Maya ^a   Shoenfeld, Yehuda ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Adjuvant; Autoantibodies; Autoimmunity; Hepatitis B; Infection; Molecular mimicry; Polyclonal activation; Vaccination

Indexed keywords

ALUMINUM; DNA POLYMERASE; DOUBLE STRANDED DNA; EPITOPE; GAMMA INTERFERON; GELATIN; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RNA DIRECTED DNA POLYMERASE; THIOMERSAL;

ANTIGEN EXPRESSION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; BYSTANDER EFFECT; DEMYELINATING DISEASE; GENETIC SUSCEPTIBILITY; GLOMERULONEPHRITIS; GRAVES DISEASE; GUILLAIN BARRE SYNDROME; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOCOMPETENT CELL; INSULIN DEPENDENT DIABETES MELLITUS; LICHEN PLANUS; MEDICAL RESEARCH; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; PEMPHIGUS; POLYARTERITIS NODOSA; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; UVEITIS; VACCINATION; IMMUNOLOGY; REVIEW;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; HEPATITIS B; HEPATITIS B VACCINES; HUMANS;

EID: 41149151780     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Miller SD, Katz-Levy Y, Neville KL, Vanderlugt CL. Virus-induced autoimmunity: epitope spreading to myelin autoepitopes in Theiler's virus infection of the central nervous system. Adv Virus Res 2001;56:199-217.
2. Chen RT, Pless R, Destefano F. Epidemiology of autoimmune reactions induced by vaccination. J Autoimmun 2001;16:309-18.
3. Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity - 'vaccinosis': a dangerous liaison? J Autoimmun 2000;14:1-10.
4. Vial T, Descotes J. Autoimmune diseases and vaccinations. Eur J Dermatol 2004;14:86-90.
5. Ravel G, Christ M, Horand F, Descotes J. Autoimmunity, environmental exposure and vaccination: is there a link? Toxicology 2004; 196:211-16.
6. Ichiki Y, He XS, Shimoda S, et al. T cell immunity in hepatitis B and hepatitis C virus infection: implications for autoimmunity. Autoimmun Rev 2005;4:82-95.
7. Piaggio E, Ben Younes A, Desbois S, et al. Hepatitis B vaccination and central nervous system demyelination: an immunological approach. J Autoimmun 2005;24:33-7.
8. Geier DA, Geier MR. A case-control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity 2005;38:295-301.
9. Berkun Y, Mimouni D, Shoenfeld Y. Pemphigus following hepatitis B vaccination - coincidence or causality? Autoimmunity 2005; 38:117-19.
10. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006;28:112-25.
11. Bertoletti A, Gehring AJ. The immune response during hepatitis B virus infection. J Gen Virol 2006;87(Pt 6):1439-49.
12. Huang CF, Lin SS, Ho YC, Chen FL, Yang CC. The immune response induced by hepatitis B virus principal antigens. Cell Mol Immunol 2006;3:97-106.
13. Wieland SF, Chisari FV. Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol 2005;79:9369-80.
14. Baumert TF, Thimme R, von Weizsacker F. Pathogenesis of hepatitis B virus infection. World J Gastroenterol 2007;13:82-90.
15. Fujinami RS, von Herrath MG, Christen U, Whitton JL. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev 2006;19:80-94.
16. Denman AM, Rager-Zisman B. Viruses: the culprits of autoimmune diseases? In: Shoenfeld Y, Rose NR, eds. Infection and Autoimmunity. Amsterdam: Elsevier, 2004:123-53.
17. Wucherpfennig KW. Mechanisms for the induction of autoimmunity by infectious agents. J Clin Invest 2001;108:1097-104.
18. Yaron T, Villanueva R. Infection and autoimmune thyroid diseases. In: Shoenfeld Y, Rose NR, eds. Infection and Autoimmunity. Amsterdam: Elsevier, 2004:515-30.
19. Matsui M, Kakigi R, Watanabe S, Kuroda Y. Recurrent demyelinating transverse myelitis in a high titer HBs-antigen carrier. J Neurol Sci 1996;139:235-7.
20. Hernan MA, Jick SS, Olek MJ, Jick H. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study. Neurology 2004;63:838-42.
21. Harada M, Fujisawa Y, Sakisaka S, et al. High prevalence of anticardiolipin antibodies in hepatitis C virus infection: lack of effects on thrombocytopenia and thrombotic complications. J Gastroenterol 2000;35:272-7.
22. Guglielmone H, Vitozzi S, Elbarcha O, Fernandez E. Cofactor dependence and isotype distribution of anticardiolipin antibodies in viral infections. Ann Rheum Dis 2001;60:500-4.
23. Martinuc Porobic J, Avcin T, Bozic B, et al. Anti-phospholipid antibodies following vaccination with recombinant hepatitis B vaccine. Clin Exp Immunol 2005;142:377-80.
24. Lee SI, Yoo WH, Yun HJ, et al. Absence of antibody to cyclic citrullinated peptide in sera of non-arthritic patients with chronic hepatitis B virus infection. Clin Rheumatol 2006;26:179.
25. Pope JE, Stevens A, Howson W, Bell DA. The development of rheumatoid arthritis after recombinant hepatitis B vaccination. J Rheumatol 1998;25:1687-93.
26. Lai KN, Lai FM, Lo S, Leung A. Is there a pathogenetic role of hepatitis B virus in lupus nephritis? Arch Pathol Lab Med 1987;111: 185-8.
27. Choffray A, Pinquier L, Bachelez H. Exacerbation of lupus panniculitis following anti-hepatitis-B vaccination. Dermatology 2007; 215:152-4.
28. Ziegenfuss J, Bergquist E, Burka E. Australia antigen in systemic lupus erythematosus. N Engl J Med 1972;286:842-3.
29. Looi LM, Prathap K. Hepatitis B virus surface antigen in glomerular immune complex deposits of patients with systemic lupus erythematosus. Histopathology 1982;6:141-7.
30. Lai KN, Lai FM, Chan KW, Chow CB, Tong KL, Vallance-Owen J. The clinico-pathologic features of hepatitis B virus-associated glomerulonephritis. Q J Med 1987;63:323-33.
31. Maggiore Q, Bartolomeo F, L'Abbate A, Misefari V. HBsAg glomerular deposits in glomerulonephritis: fact or artifact? Kidney Int 1981;19:579-86.
32. Guillevin L, Mahr A, Callard P, et al. Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 2005;84:313-22.
33. Chi ZC, Ma SZ. Rheumatologic manifestations of hepatic diseases. Hepatobiliary Pancreat Dis Int 2003;2:32-7.
34. Vento S, Cainelli F. Viral infections and autoimmune hepatitis. In: Shoenfeld Y, Rose NR, eds. Infection and Autoimmunity. Amsterdam: Elsevier, 2004:221-7.
35. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB, Taswell HF, Homburger HA. Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States. J Hepatol 1993;18:342-52.
36. Khuri KG, Shamma'a MH, Abourizk N. Hepatitis B virus markers in diabetes mellitus. Diabetes Care 1985;8:250-3.
37. Halota W, Muszynska M, Pawlowska M. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes. Med Sci Monit 2002;8:CR516-19.
38. Bogdanos DP, Mieli-Vergani G, Vergani D. Virus, liver and autoimmunity. Dig Liver Dis 2000;32:440-6.
39. Calista D, Morri M. Lichen planus induced by hepatitis B vaccination: a new case and review of the literature. Int J Dermatol 2004;43:562-4.
40. Orbach H, Shoenfeld Y. Vaccination infection and autoimmunity: myth and reality VIAMR 2005-10-26-28, Beau-Rivage Palace Hotel, Lausanne, Switzerland. Autoimmun Rev 2007;6:261-6.